• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循证医学:重新审视优先事项金字塔。

Evidence-based medicine: revisiting the pyramid of priorities.

作者信息

Rosner Anthony L

机构信息

International College of Applied Kinesiology, USA.

出版信息

J Bodyw Mov Ther. 2012 Jan;16(1):42-9. doi: 10.1016/j.jbmt.2011.05.003. Epub 2011 Jun 24.

DOI:10.1016/j.jbmt.2011.05.003
PMID:22196426
Abstract

Evidence-based medicine (EBM) is beset with numerous problems. In addition to the fact that varied audiences have each customarily sought differing types of evidence, EBM traditionally incorporated a hierarchy of clinical research designs, placing systematic reviews and meta-analyses at the pinnacle. Yet the canonical pyramid of EBM excludes numerous sources of research information, such as basic research, epidemiology, and health services research. Models of EBM commonly used by third party payers have ignored clinical judgment and patient values and expectations, which together form a tripartite and more realistic guideline to effective clinical care. Added to this is the problem in which enhanced placebo treatments in experimentation may obscure verum effects seen commonly in practice. Compounding the issue is that poor systematic reviews which comprise a significant portion of EBM are prone to subjective bias in their inclusion criteria and methodological scoring, shown to skew outcomes. Finally, the blinding concept of randomized controlled trials is particularly problematic in applications of physical medicine. Examples from the research literature in physical medicine highlight conclusions which are open to debate. More progressive components of EBM are recommended, together with greater recognition of the varying audiences employing EBM.

摘要

循证医学(EBM)面临着诸多问题。除了不同受众通常各自寻求不同类型的证据这一事实外,循证医学传统上纳入了临床研究设计的等级体系,将系统评价和荟萃分析置于顶端。然而,循证医学的经典金字塔排除了众多研究信息来源,如基础研究、流行病学和卫生服务研究。第三方支付者常用的循证医学模式忽略了临床判断以及患者的价值观和期望,而这些共同构成了有效临床护理的三方且更现实的指导原则。此外,实验中强化安慰剂治疗可能会掩盖实践中常见的真实效果这一问题也存在。使问题更加复杂的是,构成循证医学很大一部分的质量不佳的系统评价在纳入标准和方法评分方面容易出现主观偏差,这已表明会扭曲结果。最后,随机对照试验的盲法概念在物理医学应用中尤其成问题。物理医学研究文献中的例子突出了一些有待商榷的结论。建议采用循证医学中更先进的组成部分,并更多地认识到使用循证医学的不同受众。

相似文献

1
Evidence-based medicine: revisiting the pyramid of priorities.循证医学:重新审视优先事项金字塔。
J Bodyw Mov Ther. 2012 Jan;16(1):42-9. doi: 10.1016/j.jbmt.2011.05.003. Epub 2011 Jun 24.
2
Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.基于证据的医学、系统评价以及介入性疼痛管理指南:第6部分。观察性研究的系统评价与荟萃分析
Pain Physician. 2009 Sep-Oct;12(5):819-50.
3
Evidence-based alternative medicine?循证替代医学?
Perspect Biol Med. 2005 Autumn;48(4):502-15. doi: 10.1353/pbm.2005.0084.
4
An introduction to an evidence-based approach to interventional techniques in the management of chronic spinal pain.慢性脊柱疼痛管理中基于证据的介入技术方法介绍。
Pain Physician. 2009 Jul-Aug;12(4):E1-33.
5
Evidence-based medicine: what it is and what it is not.循证医学:其内涵与外延
Injury. 2006 Apr;37(4):302-6. doi: 10.1016/j.injury.2006.01.034. Epub 2006 Feb 17.
6
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence].[随机试验、系统评价、荟萃分析:科学证据领域的基本标准]
Riv Psichiatr. 2012 Jan-Feb;47(1):21-9. doi: 10.1708/1034.11288.
7
[From evidence-based medicine to medicine-based evidence].[从循证医学到基于医学的证据]
An Esp Pediatr. 2001 Nov;55(5):429-39.
8
Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.介入性疼痛管理中的循证医学、系统评价和指南,第一部分:引言与一般考虑因素
Pain Physician. 2008 Mar-Apr;11(2):161-86.
9
Evidence-based interventional pain management: principles, problems, potential and applications.循证介入性疼痛管理:原则、问题、潜力及应用
Pain Physician. 2007 Mar;10(2):329-56.
10
From data to evidence: evaluative methods in evidence-based medicine.从数据到证据:循证医学中的评估方法
Respir Care. 2001 Nov;46(11):1226-35.

引用本文的文献

1
Laser fistula treatment: beyond the controversial aspects: best clinical practice recommendations from an international group of surgeons with extensive experience in the procedure-the FiLaC recommendations.激光瘘管治疗:超越争议层面:来自一组在该手术方面经验丰富的国际外科医生的最佳临床实践建议——FiLaC 建议
Tech Coloproctol. 2025 Jun 9;29(1):131. doi: 10.1007/s10151-025-03164-w.
2
Efficacy of melatonin on drug- or contrast-induced acute kidney injury: a systematic review and GRADE-assessed meta-analysis of experimental and clinical studies.褪黑素对药物或造影剂诱导的急性肾损伤的疗效:一项对实验和临床研究的系统评价及GRADE评估的荟萃分析
Int Urol Nephrol. 2025 Jun;57(6):1865-1883. doi: 10.1007/s11255-024-04333-w. Epub 2025 Jan 9.
3
Best clinical practice recommendations for the management of symptomatic hemorrhoids via laser hemorrhoidoplasty: the LHP recommendations.激光痔切除术治疗症状性痔的最佳临床实践建议:LHP 建议。
Tech Coloproctol. 2024 Nov 23;29(1):2. doi: 10.1007/s10151-024-03022-1.
4
Insights on High-Value Procedures From the ISASS 4-Part Webinar Series on Current and Emerging Techniques in Endoscopic Spine Surgery Based on Surgeon Experience.基于外科医生经验,从国际脊柱外科学会(ISASS)关于内镜脊柱手术当前及新兴技术的四部分网络研讨会系列中获得的高价值手术见解。
Int J Spine Surg. 2024 Nov 20;18(S2):S66-S82. doi: 10.14444/8676.
5
Editorial: Embracing Rasch Analysis for Enhanced Spine Surgery Outcomes-The Outsider's Viewpoint.社论:采用拉施分析以改善脊柱手术疗效——局外人的观点
Int J Spine Surg. 2024 Nov 20;18(S2):S3-S7. doi: 10.14444/8671.
6
The Role of Pharmacogenomics in Rare Diseases.药物基因组学在罕见病中的作用。
Drug Saf. 2024 Jun;47(6):521-528. doi: 10.1007/s40264-024-01416-6. Epub 2024 Mar 14.
7
A Scoping Review of Adopted Information Extraction Methods for RCTs.随机对照试验采用的信息提取方法的范围综述
Med J Islam Repub Iran. 2023 Sep 4;37:95. doi: 10.47176/mjiri.37.95. eCollection 2023.
8
Bibliometric analysis of the top 100 cited articles in breast radiology.乳腺放射学领域被引用次数排名前100的文章的文献计量学分析。
BJR Open. 2023 May 23;5(1):20230027. doi: 10.1259/bjro.20230027. eCollection 2023.
9
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.是什么因素促使欧盟监管机构希望就 SGLT2 抑制剂相关的药物安全问题进行沟通?一项在线调查研究。
Drug Saf. 2023 Mar;46(3):243-255. doi: 10.1007/s40264-022-01270-4. Epub 2023 Feb 15.
10
The Effects of Four Weeks of Chiropractic Spinal Adjustments on Blood Biomarkers in Adults with Chronic Stroke: Secondary Outcomes of a Randomized Controlled Trial.四周整脊脊柱调整对慢性中风成人血液生物标志物的影响:一项随机对照试验的次要结果
J Clin Med. 2022 Dec 17;11(24):7493. doi: 10.3390/jcm11247493.